PFPC Daily - January 13, 2005

Celebrex Ads Were Misleading, FDA Says

LA Times - Jan. 13, 2005

Advertisements for the arthritis drug Celebrex were misleading and
unsubstantiated, overstating the pain reliever's benefits and
understating the risks, the Food and Drug Administration said.

The agency asked for an immediate halt to all ads for Celebrex, which
Pfizer Inc. did last month in advance of the agency's letter. A study
in December found high doses of Celebrex were associated with an
increased risk of heart attack.

The letter details the claims in ads for Celebrex and a related drug,
Bextra, that appeared on television, in print, on TV infomercials and
in mail brochures.

SOURCE:
http://www.latimes.com/